Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$41.12
-1.55-3.63%
At close: Jan 9, 4:00 PM EST
$41.50
-1.17-2.74%
Pre-Market: 4:38 AM EST
Comments
Loading...
Kiniksa Pharmaceuticals (KNSA) Stock Price, Quote, News & History
KNSANASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kiniksa Pharmaceuticals (KNSA) stock?
You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ:KNSA) through any online brokerage.
Who are Kiniksa Pharmaceuticals (KNSA) competitors?
Other companies in Kiniksa Pharmaceuticals’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Centessa Pharmaceuticals PLC (NASDAQ:CNTA), Ascentage Pharma Group International (NASDAQ:AAPG), Arcutis Biotherapeutics Inc (NASDAQ:ARQT) and Xenon Pharmaceuticals Inc (NASDAQ:XENE).
What is the forecast, or price target, for Kiniksa Pharmaceuticals (KNSA) stock?
Kiniksa Pharmaceuticals has a consensus price target of $47.88.
What is the current price for Kiniksa Pharmaceuticals (KNSA)?
The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $41.5 last updated January 12, 2026 at 6:42 PM EST.
Does Kiniksa Pharmaceuticals (KNSA) pay a dividend?
There are no upcoming dividends for Kiniksa Pharmaceuticals.
When is Kiniksa Pharmaceuticals (NASDAQ:KNSA) reporting earnings?
Kiniksa Pharmaceuticals does not have any upcoming earnings scheduled.
Is Kiniksa Pharmaceuticals (KNSA) going to split?
There is no upcoming split for Kiniksa Pharmaceuticals.
What sector and industry does Kiniksa Pharmaceuticals (KNSA) operate in?
Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
